ALT and AST Explained: What These Liver Enzymes Are, Why the Ratio Matters, and What Your Numbers Actually Suggest

Your liver function panel came back with two numbers flagged – ALT elevated, AST slightly elevated, ratio sitting at something your doctor is calling “interesting.” Or maybe everything looks borderline and you’re not sure what to make of it. Either way, you’re trying to figure out what ALT and AST actually are, what the ratio between them means, and whether you should be worried.

This article answers all of that – without the vagueness that makes most liver enzyme explainers so frustrating to read.


What ALT and AST Actually Are

ALT stands for alanine aminotransferase. AST stands for aspartate aminotransferase. Both are enzymes – proteins that drive chemical reactions inside cells. Under normal circumstances, they mostly stay where they belong: inside liver cells, doing their jobs. When liver cells are damaged or dying, those cells release ALT and AST into the bloodstream, where they show up on a blood test.

This is the key concept: ALT and AST are not measures of liver function. They’re markers of liver cell injury. A normal ALT doesn’t mean your liver is working well – it means your liver cells aren’t leaking. And a mildly elevated ALT doesn’t tell you how severe the problem is, just that something is causing cells to release their contents.

The distinction between the two matters:

ALT is found almost exclusively in the liver. It lives in the cytoplasm (the fluid inside the cell). Because it’s so liver-specific, an elevated ALT almost always points to the liver as the source.

AST is found in the liver too, but also in the heart, skeletal muscle, kidneys, red blood cells, and the brain. Unlike ALT, it’s present in both the cytoplasm and the mitochondria of liver cells. This dual location – and the fact that it comes from multiple organs – is what makes the ratio so useful, and so easy to misread.

The practical takeaway: ALT is the more liver-specific enzyme. AST has broader tissue distribution. When you compare them, the ratio tells you something about where the damage is coming from and how the liver cells are being injured.


Why the Ratio Exists – and What It’s Actually Measuring

The AST/ALT ratio – formally called the De Ritis ratio, after Italian physician Fernando De Ritis who described it in 1957 – isn’t just a mathematical curiosity. It reflects something biologically real about how different types of liver injury release these two enzymes.

Here’s the mechanism behind it:

Inside a liver cell (hepatocyte), AST and ALT are present in roughly a 2.5:1 ratio – there’s about 2.5 times as much AST as ALT. But AST is cleared from the bloodstream about twice as fast as ALT. AST has a serum half-life of approximately 18 hours; ALT’s half-life is around 36 hours. Because of this faster clearance, circulating levels of the two enzymes end up roughly equal in healthy people – giving a normal ratio close to 1.

When liver cells are mildly stressed or damaged at the cytoplasmic level (the cell membrane leaks, but the cell doesn’t die), mainly cytoplasmic enzymes spill out. Since both AST and ALT are in the cytoplasm, you get elevations of both – but the ratio tends to stay below 1 because ALT hangs around longer in circulation.

When liver cells die or when mitochondrial damage occurs (a deeper, more severe form of injury), mitochondrial AST is released in addition to cytoplasmic AST. Now you’re getting a bigger relative surge of AST, pushing the ratio above 1 – and in some conditions, well above 2.

This is why the ratio pattern is clinically meaningful. It reflects the type and depth of injury, not just the presence of it.


Normal Ranges: What to Expect

Reference ranges vary slightly by laboratory and by sex, but the general reference values used in most US labs are:

EnzymeMen (approximate)Women (approximate)
ALT7-56 U/L7-45 U/L
AST10-40 U/L10-34 U/L
AST/ALT Ratio0.8-1.0 (normal)0.8-1.0 (normal)

Always compare your result to the reference range printed on your own lab report – labs calibrate their equipment differently and set their own reference intervals.

One important caveat: “normal” ranges are statistical constructs based on a reference population, not hard thresholds for health. Research published in journals including Hepatology has raised questions about whether current upper limits are set too high – particularly for ALT in women – and whether values in the upper half of the “normal” range may already reflect early metabolic liver changes in some people.


What Different Ratio Patterns Suggest

This is the part of the test that carries the most diagnostic information. The absolute levels of ALT and AST matter, but the ratio between them adds a layer of interpretation that neither number alone can provide.

Ratio Below 1 (ALT Higher Than AST)

When ALT is higher than AST – meaning the ratio is less than 1 – the pattern typically points to conditions where hepatocyte damage is cytoplasmic rather than mitochondrial, and where the liver itself (rather than another organ) is the primary source.

Common causes include:

  • Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) – the most common reason for a mildly elevated ALT in the US. An ALT-dominant pattern is typical in early-stage NAFLD without significant fibrosis.
  • Viral hepatitis (hepatitis B and C) – chronic viral hepatitis almost always produces an ALT-dominant pattern, with the ratio typically well below 1. A ratio rising toward or above 1 in someone with chronic hepatitis can be a signal that fibrosis or cirrhosis is developing.
  • Drug-induced liver injury – most hepatotoxic medications produce an ALT-dominant pattern.
  • Celiac disease – can cause mild transaminase elevation, usually ALT-dominant.

Ratio Greater Than 2 (AST More Than Double ALT)

This is the pattern most clinicians flag immediately. When AST is more than twice ALT, the most established association is alcohol-related liver disease.

The mechanism is well understood: alcohol damages hepatocyte mitochondria, releasing mitochondrial AST. Additionally, alcohol depletes pyridoxal-5-phosphate (vitamin B6), which is a cofactor required for ALT synthesis – so ALT production itself is impaired in people with chronic heavy alcohol use. Both mechanisms push the ratio well above 1. According to the American Association for the Study of Liver Diseases (AASLD), around 90% of patients with alcohol-associated liver disease have an AST/ALT ratio greater than 2.

It’s worth stating clearly: an AST/ALT ratio above 2 does not diagnose alcoholic liver disease. It suggests it – and it prompts a conversation. Other causes of a ratio this high include advanced cirrhosis from any cause, certain muscle diseases, and cardiac injury (since AST is present in heart muscle). If the elevated AST is coming from somewhere other than the liver, ALT often stays relatively normal.

Ratio Between 1 and 2 (AST Modestly Higher Than ALT)

This middle pattern is less specific but not unimportant. It can reflect:

  • Cirrhosis from any cause – as scarring progresses in the liver, regardless of the original cause (viral, alcoholic, metabolic), the ratio often rises above 1. A rising AST/ALT ratio in someone with known chronic liver disease is a clinical signal worth tracking.
  • Muscle damage – intense exercise, particularly weightlifting or endurance exercise, can push AST significantly higher than ALT for several days, since muscle tissue contains high amounts of AST but little ALT. This is a common cause of a mildly abnormal ratio in otherwise healthy, active people.
  • Thyroid disease – hypothyroidism can cause mild AST elevation through muscle effects.
  • Hemolysis – AST is present in red blood cells; hemolytic conditions can raise AST without affecting ALT.

The ratio alone never makes a diagnosis. It narrows the field of possibilities and guides the next step. An AST/ALT above 2 in someone who doesn’t drink, for example, still needs full evaluation – it doesn’t rule alcohol in or out on its own.


The Magnitude of Elevation Matters Too

The ratio is one dimension. The absolute level of elevation is the other, and you need both.

A rough clinical framework:

Level of ElevationALT/ASTCommon Causes
Mild (1-3x normal)40-120 U/LNAFLD, medication effects, thyroid disease, celiac, vigorous exercise
Moderate (3-10x normal)120-400 U/LAcute viral hepatitis, alcohol-related hepatitis, drug toxicity, autoimmune hepatitis
Severe (>10x normal)>400 U/LAcute viral hepatitis, ischemic hepatitis (“shock liver”), acetaminophen toxicity, acute bile duct obstruction

Mild elevations – particularly under 3 times the upper limit of normal – are extremely common and often have benign or reversible causes. They warrant investigation but not panic. Elevations above 10 times normal are a different situation and require urgent evaluation.

It’s also worth knowing that the degree of elevation doesn’t reliably predict the severity of underlying disease. Someone with advanced cirrhosis can have only mildly elevated or even normal transaminases, because when enough liver cells have already died, there aren’t enough left to produce a major spike. End-stage liver disease can paradoxically look “calm” on a transaminase panel.


What Else Gets Checked Alongside ALT and AST

ALT and AST don’t tell the complete story of liver health, and your doctor won’t interpret them in isolation. A full liver enzyme panel typically includes:

  • Alkaline phosphatase (ALP) – elevated primarily in bile duct problems (cholestatic disease), bone disorders, or during pregnancy
  • GGT (gamma-glutamyl transferase) – particularly sensitive to alcohol use and bile duct disease; a high GGT alongside a high AST/ALT ratio strengthens the case for alcohol-related disease
  • Bilirubin – reflects how well the liver is processing waste products; elevated bilirubin suggests more significant impairment
  • Albumin and prothrombin time (PT/INR) – true markers of liver function (synthesis capacity); when these fall, it signals that the liver is losing its ability to perform its core jobs

The AASLD approach to elevated liver enzymes includes looking at the full pattern – whether the elevation is hepatocellular (transaminase-dominant) or cholestatic (ALP/bilirubin-dominant) or mixed – because that pattern guides what additional testing is needed.


Causes That Are Commonly Missed

A few things that consistently catch people off guard when their ALT or AST comes back elevated:

Exercise: Intense or prolonged exercise – particularly weightlifting, distance running, and contact sports – can raise AST significantly for days afterward. AST from muscle can reach 4 times the ALT level after heavy resistance exercise. If you exercised hard in the 48-72 hours before a blood draw, mention it to whoever ordered the test.

Medications and supplements: NSAIDs (ibuprofen, naproxen), statins, certain antibiotics, antifungals, anti-seizure medications, and some herbal supplements (including kava, green tea extract, and high-dose vitamin A) can all cause transaminase elevations. Many people don’t think to mention supplements when asked about medications.

Thyroid disease: Hypothyroidism commonly causes mild AST elevation through effects on muscle metabolism. A TSH is often checked during the workup of unexplained elevated AST.

Celiac disease: Unexplained ALT elevation – particularly in someone with gastrointestinal symptoms or who is not responding to other interventions – should prompt celiac testing.

Muscle conditions: Inflammatory muscle diseases like myositis or dermatomyositis release AST from muscle into the bloodstream, sometimes with very high AST and a relatively normal ALT. Creatine kinase (CK) is a more specific muscle enzyme and helps distinguish muscle-source AST from liver-source AST.


Frequently Asked Questions

Is an AST/ALT ratio above 2 always about alcohol? Not always – but it’s the most common cause, and it’s what the ratio was originally described to detect. An AST/ALT above 2 also occurs in advanced cirrhosis from any cause, significant muscle injury, cardiac damage, and a small number of other conditions. The ratio raises a strong suspicion but doesn’t confirm alcohol use without supporting history and other tests like GGT.

Can liver enzymes be normal even with serious liver disease? Yes. This is one of the most important things to understand about transaminases. In advanced cirrhosis, so many liver cells have already been destroyed that the remaining cells don’t produce a dramatic enzyme spike. Someone with end-stage liver disease may have normal or only mildly elevated ALT and AST. Albumin, bilirubin, and PT/INR are better markers of actual liver function in advanced disease.

My ALT is mildly elevated but everything else is normal. Do I need to worry? A single mildly elevated ALT (under 3 times normal) with no other abnormalities is common and often has a benign explanation – fatty liver, recent exercise, a medication, or normal biological variation. Your doctor will typically repeat the test and look at the full clinical picture before pursuing further workup. It usually doesn’t warrant alarm, but it does warrant follow-up.

Why does my ratio look different from what the lab flags as abnormal? The AST/ALT ratio itself isn’t always reported directly by labs – you may need to calculate it yourself by dividing AST by ALT. Labs flag individual enzyme values as high or low based on their reference ranges, but the ratio is a clinical interpretation tool rather than an automatically flagged value.

Can the ratio help identify how far liver disease has progressed? To some degree, yes. A rising AST/ALT ratio in someone with known chronic liver disease – particularly chronic viral hepatitis or NAFLD – can signal developing fibrosis or cirrhosis. Research published in peer-reviewed hepatology literature has found that a ratio rising above 1 in non-alcoholic liver disease is associated with increased likelihood of cirrhosis. It’s used as one component within broader scoring tools like the NAFLD fibrosis score. It’s informative, but not definitive on its own – a liver biopsy or non-invasive fibrosis assessment (like elastography) provides more direct information about fibrotic change.


Disclaimer

This article is for educational purposes only and does not constitute medical advice. ALT, AST, and the AST/ALT ratio must always be interpreted by a qualified healthcare provider in the context of your full clinical history, symptoms, and other laboratory findings. Do not adjust medications, change your diet, or draw conclusions about your health based solely on this content without consulting your doctor.


References

  1. Botros M, Sikaris KA. The De Ritis ratio: the test of time. Clinical Biochemist Reviews. 2013;34(3):117-130. https://pmc.ncbi.nlm.nih.gov/articles/PMC3866949/
  2. Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. Canadian Medical Association Journal. 2005;172(3):367-379. https://doi.org/10.1503/cmaj.1040752
  3. American Association for the Study of Liver Diseases (AASLD). How to approach elevated liver enzymes. https://www.aasld.org/liver-fellow-network/core-series/back-basics/how-approach-elevated-liver-enzymes
  4. Dufour DR, Lott JA, Nolte FS, et al. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clinical Chemistry. 2000;46(12):2027-2049. https://doi.org/10.1093/clinchem/46.12.2027
  5. Limdi JK, Hyde GM. Evaluation of abnormal liver function tests. Postgraduate Medical Journal. 2003;79(932):307-312. https://doi.org/10.1136/pmj.79.932.307
  6. Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology. 1988;95(3):734-739. https://pubmed.ncbi.nlm.nih.gov/3135226/
  7. Newsome PN, Cramb R, Davison SM, et al. Guidelines on the management of abnormal liver blood tests. Gut. 2018;67(1):6-19. https://doi.org/10.1136/gutjnl-2017-314924
  8. National Institute of Diabetes and Digestive and Kidney Diseases. Liver Tests. https://www.niddk.nih.gov/health-information/diagnostic-tests/liver-tests
  9. Lee TH, Kim WR, Benson JT, Therneau TM, Melton LJ 3rd. Serum aminotransferase activity and mortality risk in a United States community. Hepatology. 2008;47(3):880-887. https://doi.org/10.1002/hep.22090
  10. Medscape. Aspartate Aminotransferase (AST) – Reference Range, Interpretation, Collection and Panels. https://emedicine.medscape.com/article/2087224-overview

YOU MAY ALSO LIKE

Leave a Reply

Your email address will not be published. Required fields are marked *